Scoop has an Ethical Paywall
Licence needed for work use Learn More

World Video | Defence | Foreign Affairs | Natural Events | Trade | NZ in World News | NZ National News Video | NZ Regional News | Search

 

Global Fund Launches Corporate Champions Programme

FOR IMMEDIATE RELEASE

The Global Fund to Fight AIDS, TB and Malaria Launches Corporate Champions Programme

Inaugural partner Chevron to commit NZ$39 million

AUCKLAND, New Zealand, Jan 23, 2008 – The Global Fund to Fight AIDS, TB and malaria today announced the launch of The Global Fund Corporate Champions programme, an innovative way for multinational corporations to significantly invest in the fight against the three diseases.

Chevron Corporation is the programme’s inaugural Corporate Champion, making a commitment to invest US$30 million (NZ$ 39.8 million) over three years in Global Fund-supported programmes in parts of Asia and Africa. Chevron markets the Caltex brand in New Zealand.

The Global Fund Corporate Champions programme has been designed as an integrated platform for public private partnership, giving companies the opportunity to make a substantial commitment to global health. Each Corporate Champion will make a financial contribution to Global Fund-supported programmes in countries where it operates, thereby significantly expanding upon its own workplace and community projects and investing in high-quality, rigorously monitored and results-focused, health programmes aligned with national needs and strategies.

In addition, Corporate Champions will leverage their people and assets to improve the effectiveness and reach of health programmes. Companies can achieve this by lending their management skills and business infrastructure to the development and implementation of national strategies in the fight against AIDS, TB and malaria. Corporate Champions also are required to demonstrate a long-term commitment to fighting these global health issues. Chevron was selected as the inaugural partner as a result of its highly successful community engagement programmes tackling AIDS and malaria and its award-winning HIV/AIDS workplace programmes.

Advertisement - scroll to continue reading

“Global companies with large, long-term investments in developing countries understand that fighting disease is a necessary part of their strategic investments,” said Rajat Gupta, chairman of the Board of Directors for The Global Fund. “The Global Fund Corporate Champion programme provides the opportunity for these companies to make significant, effective, results-driven investments in national health programmes. We are extremely pleased with the commitment from Chevron. Its long-standing dedication to combating HIV/AIDS combined with its needs-based partnership approach to community engagement makes Chevron an ideal first Corporate Champion.”

“AIDS, TB and malaria are critical health threats in many of the communities where we operate around the world,” said Dave O’Reilly, Chevron chairman and CEO. “The key to the success of The Global Fund has been the strength of its partnership and collaboration model, which is an approach that Chevron shares. For a company such as ours, it makes clear business sense to join with The Global Fund and leverage resources in the fight against these diseases.”

“Chevron’s strategic investment in The Global Fund sets a standard others should aspire to,” said Ambassador Richard Holbrooke, Global Business Coalition’s president and CEO. “This exceptional new commitment to global health supplements Chevron’s ongoing programming on HIV, TB and malaria, which is already recognised as best in class. The Chevron-Global Fund partnership will enhance-already strong programmes in hard-hit regions, strengthen local communities and bring Chevron’s business skills and human resources to bear on some of the most daunting challenges of our time.”

Since its creation in 2002, The Global Fund has become the dominant multilateral financer of programmes to fight AIDS, TB and malaria, providing well over 20 percent of all international finance against AIDS and two-thirds of global financing for TB and malaria. So far, programmes supported by The Global Fund have averted 2 million deaths by providing AIDS treatment for 1.4 million people and TB treatment for 3.3 million people, and by distributing 46 million insecticide-treated bed nets that help prevent the spread of malaria.

The Global Fund is a unique public/private partnership dedicated to attracting and disbursing additional resources to prevent and treat HIV and AIDS, tuberculosis and malaria. This partnership between governments, non governmental organisations, the private sector, and affected communities represents a new approach to international health financing. The Global Fund works in close collaboration with other bilateral and multilateral organisations to supplement existing efforts dealing with the three diseases.

About Chevron
Chevron markets the Caltex brand in New Zealand, with nearly 300 service stations and Star Mart convenience stores throughout the country. Chevron New Zealand is an indirect, wholly owned subsidiary of Chevron Corporation, one of the world’s leading integrated energy companies. Chevron has approximately 58,000 employees, and operates across the entire energy spectrum — producing and transporting crude oil and natural gas; refining, marketing and distributing fuels and other energy products and services; manufacturing and selling petrochemical products; generating power; and developing and commercialising the energy resources of the future, including biofuels and other renewables. Chevron is based in San Ramon, Calif (USA). More information on Chevron is available at www.chevron.com.

ENDS

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
World Headlines

 
 
 
 
 
 
 
 
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.